Marilyne Daher, MD

Peer-Reviewed Articles

1. Daher M, Khawaja F, Spallone A, Shigle TL, Bhatti M, Vuong NN, Mulanovich V, Champlin RE, Chemaly RF. Real-World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients. Transpl Infect Dis , 2025. e-Pub 2025. PMID: 39826146.
2. Daher M, Iordanov R, Al Mohajer M, Sohail MR, Staggers KA, Hamdi AM. Clinical utility of metagenomic next-generation sequencing in fever of undetermined origin. Ther Adv Infect Dis 11:20499361241244969, 2024. e-Pub 2024. PMID: 38645300.
3. Haddadin F, Majmundar M, Jabri A, Pecha L, Scott C, Daher M, Kumar A, Kalra A, Fram R, Haddadin F, Almahameed S, DeSimone CV, Cha YM, Mulpuru SK, Ellenbogen KA, Saeed M, Chelu MG, Deshmukh AJ. Clinical outcomes and predictors of complications in patients undergoing leadless pacemaker implantation. Heart Rhythm 19(8):1289-1296, 2022. e-Pub 2022. PMID: 35490710.
4. Daher M, Varghese J, Gruschkus SK, Jimenez C, Waguespack SG, Bedrose S, Altameemi L, Bazerbashi H, Naing A, Subaiah V, Campbell MT, Shah AY, Zhang M, Sheth RA, Karam JA, Wood CG, Perrier ND, Graham PH, Lee JE, Habra MA. Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience. J Clin Endocrinol Metab 107(5):1239-1246, 2022. e-Pub 2022. PMID: 35092681.
5. Srougi V, Bancos I, Daher M, Lee JE, Graham PH, Karam JA, Henriquez A, Mckenzie TJ, Sada A, Bourdeau I, Poirier J, Vaidya A, Abbondanza T, Kiernan CM, Rao SN, Hamidi O, Sachithanandan N, Hoff AO, Chambo JL, Almeida MQ, Habra MA, Fragoso MCBV. Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival. J Clin Endocrinol Metab 107(4):964-971, 2022. e-Pub 2022. PMID: 34850915.
6. Daher M, Al Rifai M, Kherallah RY, Rodriguez F, Mahtta D, Michos ED, Khan SU, Petersen LA, Virani SS. Gender disparities in difficulty accessing healthcare and cost-related medication non-adherence: The CDC behavioral risk factor surveillance system (BRFSS) survey. Prev Med 153:106779, 2021. e-Pub 2021. PMID: 34487748.
7. Daher M, Telvizian T, Dagher C, Abdul-Sater Z, Massih SA, Chediak AE, Charafeddine M, Shahait M, Alameddine R, Temraz S, Geara F, Youssef B, El Hajj A, Nasr R, Wazzan W, Bulbul M, Khauli R, Shamseddine A, Mukherji D. High rates of advanced prostate cancer in the Middle East: Analysis from a tertiary care center. Urol Ann 13(4):418-423, 2021. e-Pub 2021. PMID: 34759656.
8. Daher M, Habra MA. Visual Vignette. Endocr Pract 26(12):1524, 2020. e-Pub 2020. PMID: 33471745.
9. Bedrose S, Miller KC, Altameemi L, Ali MS, Nassar S, Garg N, Daher M, Eaton KD, Yorio JT, Daniel DB, Campbell M, Bible KC, Ryder M, Chintakuntlawar AV, Habra MA. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. J Immunother Cancer 8(2), 2020. e-Pub 2020. PMID: 32737143.
10. Bedrose SSD, Altameemi L, Daher M, De Rosa GT, Varghese JM, Jimenez C, Campbell M, Habra MA. SAT-175 Trial in Progress Interim Report: A Phase II Clinical Trial Using Single Agent Cabozantinib in Advanced Adrenocortical Carcinoma. J Endocr Soc, 2020. e-Pub 2020.
11. Skelton M, Alameddine R, Saifi O, Hammoud M, Zorkot M, Daher M, Charafeddine M, Temraz S, Shamseddine A, Mula-Hussain L, Saleem M, Namiq KF, Dewachi O, Abu Sitta G, Abdul-Sater Z, Telvizian T, Faraj W, Mukherji D. High-Cost Cancer Treatment Across Borders in Conflict Zones: Experience of Iraqi Patients in Lebanon. JCO Glob Oncol 6:59-66, 2020. e-Pub 2020. PMID: 32031440.

Review Articles

1. Triska J, Haddadin F, Madanat L, Jabri A, Daher M, Birnbaum Y, Jneid H. The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Cardiovasc Drugs Ther 38(3):605-619, 2024. e-Pub 2024. PMID: 35829979.
2. Khawaja F, Daher M, Spallone A, Chemaly RF. COVID-19 Vaccination in Patients With Cancer and Recipients of Cellular Therapy. Oncology (Williston Park) 37(2):69-77, 2023. e-Pub 2023. PMID: 36862845.
3. Mahtta D, Daher M, Lee MT, Sayani S, Shishehbor M, Virani SS. Promise and Perils of Telehealth in the Current Era. Curr Cardiol Rep 23(9):115, 2021. e-Pub 2021. PMID: 34269884.
4. Borgaonkar S, Hahn J, Daher M, Kayani W, Jneid H. Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era. Curr Cardiol Rep 23(6):69, 2021. e-Pub 2021. PMID: 33961122.
5. Bedrose S, Daher M, Altameemi L, Habra MA. Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions. Cancers (Basel) 12(2), 2020. e-Pub 2020. PMID: 32098326.

Abstracts

1. Ostos-Mendoza K, Chen L, Lopez-Rodriguez AS, Daher M, Ali A, Koutroumpakis E, Song J, Ali H, Iliescu C, Yusuf WS, Khalaf S, Subudhi SK, Deswal A, Siddiqui BA, Palaskas NL. Early targeted biologics and steroids yielded no major cardiovascular events in ICI-related myocarditis. American Heart Association. e-Pub 2024.
2. Daher M, Iordanov R, Hamdi AM. Clinical Utility of Metagenomic Next-Generation Sequencing in Fever of Unclear Etiology: a Single Center Retrospective Cohort Study. IDWeek, 2022. e-Pub 2022.
3. Daher M, Khawaja F, Angelidakis G, Rondon G, Spallone A, Ramdial J, Ariza-Heredia E, Shpall E, Chemaly RF. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients. IDWeek, 2022. e-Pub 2022.
4. Haddadin F, Majmundar M, Pecha R, Scott C, Daher M, AlMahameed S, DeSimone CV, Cha Y, Mulpuru SK, Ellenbogen KA, Saeed M, Chelu MG, Deshmukh AJ. Comorbidities, Clinical Outcomes and Predictors of Complications in Patients with Leadless Pacemaker. Heart Rhythm Society, 2022. e-Pub 2022.
5. Suffredini JM, Daher M, Jneid H, Denktas AE, Khalid M, Paniagua D. Contrast Minimization Devices in the Cath Lab: Real-World Outcomes Within a VA Hospital. American Heart Association 144, 2021. e-Pub 2021.
6. Kabani S, Daher M, Segura A, Bihong Z, Lelenwa L, Buja M, Iliescu C, Deswal A, Palaskas N. Immune Checkpoint Inhibitor Myocarditis Hemodynamics on Presentation. American College of Cardiology - 2021 ACC, 2021. e-Pub 2021.
7. Mukherji D, Skeleton M, Alameddine R, Saifi O, Hammoud MS, Daher M, Charafeddine M, Faraj W, Temraz SN, Shamseddine A, Mula-Hussain LYI, Saleem M, Namiq KF, Dewachi O, Abu Sitta G. Financial toxicity associated with conflict-induced cross-border travel for cancer care: Experience of Iraqi patients in Lebanon. 2018 ASCO Annual Meeting, 2018. e-Pub 2018.
8. Mukherji D, Abed El Massih S, Daher M, Chediak A, Charafeddine M, Shahait M, Temraz SN, Geara FB, El Hajj A, Nasr R, Wazzan W, Bulbul M, Khauli R, Shamseddine A. Prostate cancer stage at diagnosis: First data from a Middle-Eastern cohort. ASCO: Genitourinary Cancers Symposium 35, 2017. e-Pub 2017.
9. Guy H, Yusuke O, Tali S, Vielka L, Daher M, Amy S, Gabriela R, Rohtesh M, Richard C, Elizabeth S, Fareed K, Roy C. Human Herpesvirus 6 Reactivation within the First Year after Haploidentical Transplantation: Experience from a Major Cancer Center. Tandem Conference.
10. Khawaja F, Daher M. Cytomegalovirus end organ disease after allogeneic hematopoietic cell transplant- descriptive and comparative analysis in the era of letermovir prophylaxis. Tandem Conference.
11. Ohashi Y, Chemaly RF, Khawaja F, Daher M, Spallone A, Shafat T, Ariza-Heredia EJ, Handley G. Factors Associated with Human Herpesvirus 6 DNAemia Among Allogeneic Hematopoietic Cell Transplant Recipients in the Modern Era. IDWeek.
12. Handley G, Ohashi Y, Shafat T, Lopez V, Daher M, Spallone A, Rondon G, Mehta RS, Champlin RE, Shpall EJ, Khawaja F, Chemaly RF. “Human Herpesvirus 6 Reactivation within the First Year after Haploidentical Transplantation: Experience from a Major Cancer Center”.
13. Yosef TS, Khawaja F, Shafat T, Shigle TL, Daher M, Lopez V, Rondon G, Shpall EJ, Champlin RE, Heredia EA, Spallone A, Handley G, Chemaly RF. “Cytomegalovirus end -organ disease after allogeneic hematopoietic cell transplant- descriptive and comparative analysis in the era of Letermovir prophylaxis”. American Society for Transplantation and Cellular Therapy.
14. Shafat T, Khawaja F, Daher M, Jiang Y, Chemaly RF. The interplay between EBV and CMV reactivations following allogeneic hematopoietic cell transplantation in the era of primary CMV prophylaxis. ASTCT.
15. Khawaja F, Daher M, Makhoul J, Lopez V, Shafat T, Spallone A, Shigle TL, Sassine J, Febres A, Morado O, Ariza-Heredia EJ, Chemaly RF. Risk Factors and Outcomes of Resistant CMV Infections in Hematopoietic Cell Transplant Recipients: a 7-Year Review. IDWeek.

Letters to the Editor

1. Krittanawong C, Hahn J, Daher M, Mahtta D, Narasimhan B, Wang Z, Bandyopadhyay D, Sharma SK, Alam M, Jneid H, Virani SS. A comparison of cardiovascular risk factors between Asian-Americans and non-Asian Americans: An analysis from the NHANES database. Prog Cardiovasc Dis 68: 94-96, 2021.
2. Krittanawong C, Daher M, Hahn J, Narasimhan B, Wang Z, Alam M, Jneid H, Virani SS. Gender Differences in Premature Coronary Artery Disease (from the National Data from the NHANES Database). Am J Cardiol 153: 142-144, 2021.
3. Daher M, Al Rifai M, Mahtta D, Krittanawong C, Berman J, Ullah W, Alam M, Virani SS. Substance Use and Premature Atherosclerotic Cardiovascular Disease (From the CDC Behavioral Risk Factor Surveillance System [BRFSS] Survey). Am J Cardiol 152: 177-178, 2021.

Web Publications

1. Shafat T, Khawaja F, Daher M, Jiang Y, Chemaly RF. The Interplay between EBV and CMV Reactivations Following Allogeneic Hematopoietic Cell Transplantation in the Era of Primary CMV Prophylaxis.